Literature DB >> 28956218

Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.

Hitesh S Purohit1, Lynne S Taylor2.   

Abstract

PURPOSE: The aim of this research was to study the interplay of solid and solution state phase transformations during the dissolution of ritonavir (RTV) amorphous solid dispersions (ASDs).
METHODS: RTV ASDs with polyvinylpyrrolidone (PVP), polyvinylpyrrolidone vinyl acetate (PVPVA) and hydroxypropyl methylcellulose acetate succinate (HPMCAS) were prepared at 10-50% drug loading by solvent evaporation. The miscibility of RTV ASDs was studied before and after exposure to 97% relative humidity (RH). Non-sink dissolution studies were performed on fresh and moisture-exposed ASDs. RTV and polymer release were monitored using ultraviolet-visible spectroscopy. Techniques including fluorescence spectroscopy, confocal imaging, scanning electron microscopy (SEM), atomic force microscopy (AFM), differential scanning calorimetry (DSC) and nanoparticle tracking analysis (NTA) were utilized to monitor solid and the solution state phase transformations.
RESULTS: All RTV-PVP and RTV-PVPVA ASDs underwent moisture-induced amorphous-amorphous phase separation (AAPS) on high RH storage whereas RTV-HPMCAS ASDs remained miscible. Non-sink dissolution of PVP- and PVPVA-based ASDs at low drug loadings led to rapid RTV and polymer release resulting in concentrations in excess of amorphous solubility, liquid-liquid phase separation (LLPS) and amorphous nanodroplet formation. High drug loading PVP- and PVPVA-based ASDs did not exhibit LLPS upon dissolution as a consequence of extensive AAPS in the hydrated ASD matrix. All RTV-HPMCAS ASDs led to LLPS upon dissolution.
CONCLUSIONS: RTV ASD dissolution is governed by a competition between the dissolution rate and the rate of phase separation in the hydrated ASD matrix. LLPS was observed for ASDs where the drug release was polymer controlled and only ASDs that remained miscible during the initial phase of dissolution led to LLPS. Techniques such as fluorescence spectroscopy, confocal imaging and SEM were useful in understanding the phase behavior of ASDs upon hydration and dissolution and were helpful in elucidating the mechanism of generation of amorphous nanodroplets.

Entities:  

Keywords:  amorphous solid dispersion; amorphous-amorphous phase separation; dissolution; fluorescence spectroscopy; liquid-liquid phase separation

Mesh:

Substances:

Year:  2017        PMID: 28956218     DOI: 10.1007/s11095-017-2265-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  31 in total

Review 1.  Bridging solubility between drug discovery and development.

Authors:  Li Di; Paul V Fish; Takashi Mano
Journal:  Drug Discov Today       Date:  2011-11-26       Impact factor: 7.851

2.  Dissolution rates of high energy sulfathiazole--povidone coprecipitates II: characterization of form of drug controlling its dissolution rate via solubility studies.

Authors:  A P Simonelli; S C Mehta; W I Higuchi
Journal:  J Pharm Sci       Date:  1976-03       Impact factor: 3.534

3.  Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.

Authors:  Sharad B Murdande; Michael J Pikal; Ravi M Shanker; Robin H Bogner
Journal:  J Pharm Sci       Date:  2010-03       Impact factor: 3.534

4.  Understanding the tendency of amorphous solid dispersions to undergo amorphous-amorphous phase separation in the presence of absorbed moisture.

Authors:  Alfred C F Rumondor; Håkan Wikström; Bernard Van Eerdenbrugh; Lynne S Taylor
Journal:  AAPS PharmSciTech       Date:  2011-09-17       Impact factor: 3.246

5.  Early stage phase separation in pharmaceutical solid dispersion thin films under high humidity: improved spatial understanding using probe-based thermal and spectroscopic nanocharacterization methods.

Authors:  Sheng Qi; Jonathan G Moffat; Ziyi Yang
Journal:  Mol Pharm       Date:  2013-01-28       Impact factor: 4.939

Review 6.  Physical chemistry of supersaturated solutions and implications for oral absorption.

Authors:  Lynne S Taylor; Geoff G Z Zhang
Journal:  Adv Drug Deliv Rev       Date:  2016-03-22       Impact factor: 15.470

7.  Mechanism of Dissolution-Induced Nanoparticle Formation from a Copovidone-Based Amorphous Solid Dispersion.

Authors:  Paul Harmon; Kendra Galipeau; Wei Xu; Chad Brown; W Peter Wuelfing
Journal:  Mol Pharm       Date:  2016-04-11       Impact factor: 4.939

8.  Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone).

Authors:  Patrick J Marsac; Alfred C F Rumondor; David E Nivens; Umesh S Kestur; Lia Stanciu; Lynne S Taylor
Journal:  J Pharm Sci       Date:  2010-01       Impact factor: 3.534

9.  Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.

Authors:  Yuejie Chen; Shujing Wang; Shan Wang; Chengyu Liu; Ching Su; Michael Hageman; Munir Hussain; Roy Haskell; Kevin Stefanski; Feng Qian
Journal:  Pharm Res       Date:  2016-06-09       Impact factor: 4.200

10.  Spectrofluorometric studies of the lipid probe, nile red.

Authors:  P Greenspan; S D Fowler
Journal:  J Lipid Res       Date:  1985-07       Impact factor: 5.922

View more
  8 in total

1.  Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.

Authors:  Clara E Correa Soto; Yi Gao; Anura S Indulkar; Keisuke Ueda; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2022-01-10       Impact factor: 4.200

2.  Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.

Authors:  Anura S Indulkar; Xiaochun Lou; Geoff G Z Zhang; Lynne S Taylor
Journal:  Pharm Res       Date:  2022-02-15       Impact factor: 4.200

Review 3.  Drug-Rich Phases Induced by Amorphous Solid Dispersion: Arbitrary or Intentional Goal in Oral Drug Delivery?

Authors:  Kaijie Qian; Lorenzo Stella; David S Jones; Gavin P Andrews; Huachuan Du; Yiwei Tian
Journal:  Pharmaceutics       Date:  2021-06-15       Impact factor: 6.321

4.  Influence of Particle Size and Drug Load on Amorphous Solid Dispersions Containing pH-Dependent Soluble Polymers and the Weak Base Ketoconazole.

Authors:  Marius Monschke; Kevin Kayser; Karl G Wagner
Journal:  AAPS PharmSciTech       Date:  2021-01-12       Impact factor: 3.246

5.  Exploring the Role of Surfactants in Enhancing Drug Release from Amorphous Solid Dispersions at Higher Drug Loadings.

Authors:  Sugandha Saboo; Pradnya Bapat; Dana E Moseson; Umesh S Kestur; Lynne S Taylor
Journal:  Pharmaceutics       Date:  2021-05-17       Impact factor: 6.321

6.  Impact of HPMCAS on the Dissolution Performance of Polyvinyl Alcohol Celecoxib Amorphous Solid Dispersions.

Authors:  Marius Monschke; Karl G Wagner
Journal:  Pharmaceutics       Date:  2020-06-11       Impact factor: 6.321

7.  Amorphous solid dispersion formation via solvent granulation - A case study with ritonavir and lopinavir.

Authors:  Niraj S Trasi; Sonal Bhujbal; Qi Tony Zhou; Lynne S Taylor
Journal:  Int J Pharm X       Date:  2019-11-12

8.  Water-Induced Phase Separation of Spray-Dried Amorphous Solid Dispersions.

Authors:  Na Li; Jonathan L Cape; Bharat R Mankani; Dmitry Y Zemlyanov; Kimberly B Shepard; Michael M Morgen; Lynne S Taylor
Journal:  Mol Pharm       Date:  2020-09-24       Impact factor: 4.939

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.